Fermentalg SA (EPA:ALGAE)
0.410
-0.010 (-2.38%)
Mar 9, 2026, 5:35 PM CET
Fermentalg Revenue
Fermentalg had revenue of 7.61M EUR in the half year ending June 30, 2025, with 225.00% growth. This brings the company's revenue in the last twelve months to 12.78M, up 59.10% year-over-year. In the year 2024, Fermentalg had annual revenue of 11.50M with 183.39% growth.
Revenue (ttm)
12.78M
Revenue Growth
+59.10%
P/S Ratio
2.95
Revenue / Employee
202.92K
Employees
63
Market Cap
37.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.50M | 7.44M | 183.39% |
| Dec 31, 2023 | 4.06M | -3.59M | -46.95% |
| Dec 31, 2022 | 7.65M | 2.00M | 35.43% |
| Dec 31, 2021 | 5.65M | 3.44M | 156.10% |
| Dec 31, 2020 | 2.21M | -1.87M | -45.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nicox | 3.32M |
| THX Pharma Société Anonyme | 876.13K |
| Advicenne | 5.90M |
| genOway Société anonyme | 27.16M |
| GenSight Biologics | 945.00K |
| Valerio Therapeutics Société anonyme | 1.83M |
| Aelis Farma | 2.33M |
| OSE Immunotherapeutics | 1.78M |